Greenstar Biosciences Corp., a growth-oriented technology and services company, provides real estate, financial, management, intellectual property, and branding support to licensed cannabis businesses in the United States.
The last earnings update was 108 days ago.
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Greenstar Biosciences. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Greenstar Biosciences's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Greenstar Biosciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Real Estate industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Greenstar Biosciences's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Greenstar Biosciences's earnings growth to the Canada market average as no estimate data is available.
Unable to compare Greenstar Biosciences's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if Greenstar Biosciences is high growth as no earnings estimate data is available.
Unable to determine if Greenstar Biosciences is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Greenstar Biosciences's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Greenstar Biosciences's finances.
The net worth of a company is the difference between its assets and liabilities.
Greenstar Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Greenstar Biosciences's long term commitments exceed its cash and other short term assets.
This treemap shows a more detailed breakdown of
Greenstar Biosciences's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Low level of unsold assets.
Greenstar Biosciences has no debt, it does not need to be covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
Mr. Rahim Rajwani serves as Chief Executive Officer at Greenstar Biosciences Corp and has beent its Corporate Secretary since July 2019. Mr. Rajwani is the Director at Block X Capital Corp since November 2018. He serves as Director at Sherpa II Holdings Corp. Mr. Rajwani served as an Interim Chief Executive Officer of Block X Capital Corp. (f/k/a Lions Gate Metals Inc.) since July 10, 2018 until February 12, 2019. and its Chief Financial Officer since January 2018 until February 12, 2019. He has over 22 years of public and private company experience. Mr. Rajwani began his career at Yorkton Securities in 1994, and then later moved on to Union Securities where he worked as Chief Compliance Officer and Vice President of Compliance with a primary focus on risk mitigation. He served in successive roles of increasing responsibility at Salman Partners, moving from Chief Compliance Officer, to Vice President, to Managing Director. Mr. Rajwani served as a Director of MK2 Ventures Ltd. from October 23, 2017 to July 6, 2018. He aims to bestow his expertise in the regulatory, compliance, risk mitigation, and M&A transaction fields in order to support Block X's process of identification, evaluation, and investment in the most promising blockchain and emerging technology companies. As an executive member of Peninsula Merchant Syndications Corp., Mr. Rajwani was involved in a number of capital market negotiations and advisory engagements including Ventana Gold. He currently serves as an M&A advisory consultant. Mr. Rajwani graduated from the University of British Columbia.
Insufficient data for Rahim to compare compensation growth.
Insufficient data for Rahim to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
CEO & Corporate Secretary
Chief Financial Officer
Chief Operating Officer
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The average tenure for the Greenstar Biosciences board of directors is less than 3 years, this suggests a new board.
Board of Directors
Member of Strategic Advisory Board
Member of Strategic Advisory Board
Who owns this company?
Recent Insider Trading
More shares have been bought than sold by Greenstar Biosciences individual insiders in the past 3 months, but not in substantial volumes.
Greenstar Biosciences Corp., a growth-oriented technology and services company, provides real estate, financial, management, intellectual property, and branding support to licensed cannabis businesses in the United States. The company is headquartered in Calgary, Canada.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.